Defence Therapeutics Inc. | WebDisclosure

Basculer en Français

8643	Companies
145633	Keywords
81395	Articles
77989	Press releases

Headlines Articles Press releases Defence Therapeutics Inc.

Home
Companies
Defence Therapeutics Inc.

PRESS RELEASE

published on 06/17/2024 at 08:00, 10 months 18 days ago

DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN
Defence Therapeutics Inc.'s Chief Scientific Officer Dr. Moutih Rafei discusses the ACCUM platform for cancer treatments on Money Talk Radio with Ellis Martin

Defence Therapeutics Inc. Cancer Treatments ACCUM Platform Dr. Moutih Rafei Money Talk Radio
BRIEF

published on 06/10/2024 at 08:05, 10 months 25 days ago

Defence Therapeutics participera au congrès annuel 2024 du SNMMI à Toronto

Thérapeutique De Défense SNMMI AccuTRIC™ Médecine Nucléaire Imagerie Moléculaire
BRIEF

published on 06/10/2024 at 08:05, 10 months 25 days ago

Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto

Defence Therapeutics Nuclear Medicine SNMMI AccuTRIC™ Molecular Imaging
PRESS RELEASE

published on 06/10/2024 at 08:00, 10 months 25 days ago

DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024
Defence Therapeutics Inc. to participate in the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024, presenting their novel Radio-Immuno-Conjugate (RIC) for cancer treatment

Cancer Treatment Defence Therapeutics Inc. Molecular Imaging Society Of Nuclear Medicine Radio-Immuno-Conjugate
BRIEF

published on 06/06/2024 at 08:05, 10 months 29 days ago

L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine

Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRIEF

published on 06/06/2024 at 08:05, 10 months 29 days ago

Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine

Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
PRESS RELEASE

published on 06/06/2024 at 08:00, 10 months 29 days ago

DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Defence Therapeutics Inc.'s AccuTOX published in the prestigious Journal of Translational Medicine along with preclinical data on AccuTOX as an anti-cancer molecule. Study highlights AccuTOX's superior therapeutic properties and versatility for different cancer treatments

Preclinical Data Defence Therapeutics Inc. AccuTOX Journal Of Translational Medicine Anti-cancer Molecule
BRIEF

published on 05/14/2024 at 08:05, 11 months 22 days ago

Defence Therapeutics étend son portefeuille de brevets à l'échelle mondiale

Thérapeutique De Défense Délivrance De Brevet Innovation Dans Les Soins De Santé Vaccin Immuno-oncologique Système De Délivrance De Médicaments
BRIEF

published on 05/14/2024 at 08:05, 11 months 22 days ago

Defence Therapeutics Expands Patent Portfolio Globally

Defence Therapeutics Patent Issuance Drug Delivery System Innovation In Healthcare Immune-Oncology Vaccine
PRESS RELEASE

published on 05/14/2024 at 08:00, 11 months 22 days ago

DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES
Defence Therapeutics strengthens and expands global patent protection on key technologies, including vaccine enhancer platform and ADC platform technology. The new patents and allowances showcase the company's commitment to innovation in biopharmaceuticals

Biopharmaceuticals Defence Therapeutics Patent Protection Vaccine Enhancer ADC Platform Technology

Accesswire

Published on 05/06/2025 at 00:20, 1 hour 27 minutes ago

McFarlane Lake Announces Listing on the Canadian Securities Exchange (CSE) Effective Thursday, May 8, 2025
Published on 05/05/2025 at 20:00, 5 hours 47 minutes ago

PPX Mining Announces Closing of Oversubscribed Private Placement
Published on 05/05/2025 at 15:10, 10 hours 37 minutes ago

Star Gold Corp. Refocuses Strategy on Longstreet Project
Published on 05/05/2025 at 14:30, 11 hours 17 minutes ago

Gladstone Capital Corporation Earnings Call and Webcast Information
Published on 05/05/2025 at 14:00, 11 hours 47 minutes ago

Boron One Holdings Inc. Signs Letter of Intent

View all ACCESSWIRE

EQS Group

Published on 05/05/2025 at 19:05, 6 hours 42 minutes ago

namR: Homologation du protocole de conciliation pour la cession d’actifs auprès d’Addactis
Published on 05/05/2025 at 19:00, 6 hours 47 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 28 AVRIL 2025 au 02 MAI 2025
Published on 05/05/2025 at 18:30, 7 hours 17 minutes ago

Avolta Expands at JFK Terminal 5 with New Dining, Retail, and Video Gaming Experiences
Published on 05/05/2025 at 18:00, 7 hours 47 minutes ago

E-PANGO: Composition du capital au 30 avril 2025
Published on 05/05/2025 at 17:55, 7 hours 52 minutes ago

AFYREN and Südzucker celebrate 5 years of strategic bioeconomy partnership

Les Echos

Published on 05/05/2025 at 19:00, 6 hours 47 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 05/05/2025 at 19:00, 6 hours 47 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AVRIL 2025
Published on 05/05/2025 at 19:00, 6 hours 47 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 05/05/2025 at 19:00, 6 hours 47 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AVRIL 2025
Published on 05/05/2025 at 17:45, 8 hours 2 minutes ago

Fire safety: Chubb France deploys AMA's assisted reality for remote troubleshooting

View all LES ECHOS COMFI WIRE